Catabasis Pharmaceuticals to Present at Oppenheimer’s 27th Annual Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Catabasis
Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutical company, today announced that Jill C. Milne, Ph.D.,
Chief Executive Officer, will present a corporate and pipeline overview
at Oppenheimer’s 27^th Annual Healthcare Conference on March
22, 2017 at 3:20pm ET at the Westin New York Grand Central Hotel in New
York City, NY.

A webcast of the presentation will be available in the Investors section
of the Company’s website, www.catabasis.com,
and will be archived for 30 days following the presentation.

About Catabasis

At Catabasis Pharmaceuticals, our mission is to bring hope and
life-changing therapies to patients and their families. Our SMART
(Safely Metabolized And Rationally Targeted) linker drug discovery
platform enables us to engineer molecules that simultaneously modulate
multiple targets in a disease. We are applying our SMART linker platform
to build an internal pipeline of product candidates for rare diseases
and plan to pursue partnerships to develop additional product
candidates. For more information on the Company’s drug discovery
platform and pipeline of drug candidates, please visit www.catabasis.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170315005034/en/